BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25455954)

  • 1. [Screening and management of cardiovascular risk factors in systemic lupus erythematosus: Recommendations for clinical practice based on the literature and expert opinion].
    Arnaud L; Mathian A; Adoue D; Bader-Meunier B; Baudouin V; Belizna C; Bonnotte B; Boumedine F; Chaib A; Chauchard M; Chiche L; Daugas E; Ghali A; Gobert P; Gondran G; Guettrot-Imbert G; Hachulla E; Hamidou M; Haroche J; Hervier B; Hummel A; Jourde-Chiche N; Korganow AS; Kwon T; Le Guern V; Le Quellec A; Limal N; Magy-Bertrand N; Marianetti-Guingel P; Martin T; Martin Silva N; Meyer O; Miyara M; Morell-Dubois S; Ninet J; Papo T; Pennaforte JL; Polomat K; Pourrat J; Queyrel V; Raymond I; Remy P; Sacre K; Schmidt J; Sibilia J; Viallard JF; Viau Brabant A; Wahl D; Bruckert E; Amoura Z;
    Rev Med Interne; 2015 Jun; 36(6):372-80. PubMed ID: 25455954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention of infections in adults and adolescents with systemic lupus erythematosus: Guidelines for the clinical practice based on the literature and expert opinion].
    Mathian A; Arnaud L; Adoue D; Agard C; Bader-Meunier B; Baudouin V; Belizna C; Bonnotte B; Boumedine F; Chaib A; Chauchard M; Chiche L; Daugas E; Ghali A; Gobert P; Gondran G; Guettrot-Imbert G; Hachulla E; Hamidou M; Haroche J; Hervier B; Hummel A; Jourde-Chiche N; Korganow AS; Kwon T; Le Guern V; Le Quellec A; Limal N; Magy-Bertrand N; Marianetti-Guingel P; Martin T; Martin Silva N; Meyer O; Miyara M; Morell-Dubois S; Ninet J; Pennaforte JL; Polomat K; Pourrat J; Queyrel V; Raymond I; Remy P; Sacre K; Sibilia J; Viallard JF; Viau Brabant A; Hanslik T; Amoura Z;
    Rev Med Interne; 2016 May; 37(5):307-20. PubMed ID: 26899776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessing the cardiovascular risk in patients with systemic lupus erythematosus].
    Arnaud L; Mathian A; Bruckert E; Amoura Z
    Rev Med Interne; 2014 Nov; 35(11):723-9. PubMed ID: 25234464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P; Atzeni F; Carrabba M
    Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? a critical appraisal.
    Tselios K; Koumaras C; Urowitz MB; Gladman DD
    Semin Arthritis Rheum; 2014 Feb; 43(4):521-5. PubMed ID: 23953498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
    Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG
    Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiovascular monitoring of patients with systemic lupus erythematosus].
    Schotte H; Becker H; Domschke W; Gaubitz M
    Z Rheumatol; 2005 Nov; 64(8):564-75. PubMed ID: 16328762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus.
    Keeling SO; Alabdurubalnabi Z; Avina-Zubieta A; Barr S; Bergeron L; Bernatsky S; Bourre-Tessier J; Clarke A; Baril-Dionne A; Dutz J; Ensworth S; Fifi-Mah A; Fortin PR; Gladman DD; Haaland D; Hanly JG; Hiraki LT; Hussein S; Legault K; Levy D; Lim L; Matsos M; McDonald EG; Medina-Rosas J; Pardo Pardi J; Peschken C; Pineau C; Pope J; Rader T; Reynolds J; Silverman E; Tselios K; Suitner M; Urowitz M; Touma Z; Vinet E; Santesso N
    J Rheumatol; 2018 Oct; 45(10):1426-1439. PubMed ID: 30173152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies.
    Mosca M; Tani C; Aringer M; Bombardieri S; Boumpas D; Brey R; Cervera R; Doria A; Jayne D; Khamashta MA; Kuhn A; Gordon C; Petri M; Rekvig OP; Schneider M; Sherer Y; Shoenfeld Y; Smolen JS; Talarico R; Tincani A; van Vollenhoven RF; Ward MM; Werth VP; Carmona L
    Ann Rheum Dis; 2010 Jul; 69(7):1269-74. PubMed ID: 19892750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors, burden of disease and preventive strategies in patients with systemic lupus erythematosus: a literature review.
    Benvenuti F; Gatto M; Larosa M; Iaccarino L; Punzi L; Doria A
    Expert Opin Drug Saf; 2015; 14(9):1373-85. PubMed ID: 26212119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention of cardiovascular disease in patients with systemic lupus erythematosus: case series and literature review.
    Fasano S; Margiotta DP; Navarini L; Pierro L; Pantano I; Riccardi A; Afeltra A; Valentini G
    Lupus; 2017 Dec; 26(14):1463-1472. PubMed ID: 28786768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus.
    Kleinmann JF; Tubach F; Le Guern V; Mathian A; Richez C; Saadoun D; Sacre K; Sellam J; Seror R; Amoura Z; Andres E; Audia S; Bader-Meunier B; Blaison G; Bonnotte B; Cacoub P; Caillard S; Chiche L; Chosidow O; Costedoat-Chalumeau N; Daien C; Daugas E; Derdèche N; Doria A; Fain O; Fakhouri F; Farge D; Gabay C; Guillo S; Hachulla E; Hajjaj-Hassouni N; Hamidou M; Houssiau FA; Jourde-Chiche N; Koné-Paut I; Ladjouz-Rezig A; Lambotte O; Lipsker D; Mariette X; Martin-Silva N; Martin T; Maurier F; Meckenstock R; Mékinian A; Meyer O; Mohamed S; Morel J; Moulin B; Mulleman D; Papo T; Poindron V; Puéchal X; Punzi L; Quartier P; Sailler L; Smail A; Soubrier M; Sparsa A; Tazi-Mezalek Z; Zakraoui L; Zuily S; Sibilia J; Gottenberg JE
    Autoimmun Rev; 2017 Jun; 16(6):650-657. PubMed ID: 28434948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriate cardiovascular disease risk assessment in systemic lupus erythematosus may be lacking in rheumatology practice.
    Esmaeilbeigi F; Pope JE
    Clin Exp Rheumatol; 2018; 36(4):526-532. PubMed ID: 29846162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk stratification and appropriate use of statins in patients with systemic lupus erythematosus according to different strategies.
    Masson W; Rossi E; Mora-Crespo LM; Cornejo-Peña G; Pessio C; Gago M; Alvarado RN; Scolnik M
    Clin Rheumatol; 2020 Feb; 39(2):455-462. PubMed ID: 31802350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.
    Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe IM; Houssiau F; Huizinga T; Isenberg D; Kallenberg CG; Khamashta M; Piette JC; Schneider M; Smolen J; Sturfelt G; Tincani A; van Vollenhoven R; Gordon C; Boumpas DT;
    Ann Rheum Dis; 2008 Feb; 67(2):195-205. PubMed ID: 17504841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of antiphospholipid syndrome].
    Saadoun D; Piette JC; Wahl D; Costedoat-Chalumeau N
    Rev Med Interne; 2012 Apr; 33(4):217-22. PubMed ID: 22360832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies.
    Turano L
    J Cardiovasc Nurs; 2013; 28(1):48-53. PubMed ID: 22210142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective cohort studies on risk factors for cardiovascular events in systemic lupus erythematosus: a major challenge.
    Bultink IE
    Arthritis Res Ther; 2010; 12(1):107. PubMed ID: 20236499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease.
    Haque S; Bruce IN
    Nat Clin Pract Cardiovasc Med; 2005 Aug; 2(8):423-30. PubMed ID: 16119705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High cardiovascular complications in systemic lupus erythematosus: physiopathology and risk management].
    Boffa JJ; Rougier JP; Noël N; Ronco P
    Nephrol Ther; 2009 Dec; 5(7):595-602. PubMed ID: 19733524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.